US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Adoption of Artificial Intelligence in the Indian Healthcare Industry : Development of Go-To-Market (GTM) Business Strategy

In April 2020, Meticulous Research’s consultants received a study scope from this client. As per the study scope, the client was majorly interested in knowing the opportunity assessment of AI in the Indian healthcare sector and the acceptance of technology-based services by Indian healthcare professionals and consumers.

Key Highlights:

Problem Statement:

The client is one of the leading manufacturers of advanced technology solutions used in various industries worldwide. The company focuses on the R&D of AI-based products for medical professionals to maximize the quality of care. The client was interested in geographical expansion opportunities in other countries. He desired to start this expansion in India. For expanding its presence, the company needed to formulate the Go-To-Market (GTM) business strategy for the introduction of AI-based technology products in Indian hospitals.

In April 2020, Meticulous Research’s consultants received a study scope from this client. As per the study scope, the client was majorly interested in knowing the opportunity assessment of AI in the Indian healthcare sector and the acceptance of technology-based services by Indian healthcare professionals and consumers. Moreover, the client wanted thorough qualitative and quantitative information on the penetration of telemedicine for consultation services and care delivery in the Indian healthcare sector. In order to gain clarity on the penetration rate, the client had asked Meticulous Research to provide telehealth value chain analysis, pricing strategy, and payment modes adopted by major players, product offering of major players in telemedicine, and teleconsultation adoption rate. The client also wanted to know the regulatory challenges associated with AI in healthcare; end-user perception analysis for digital clinics; and market entry strategies in telemedicine, drug discovery, and precision medicine segments.

Download a Copy